The company’s management will webcast a corresponding conference call beginning at
About
With its corporate headquarters in
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Source:
2024 GlobeNewswire, Inc., source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +0.36% | -2.48% | -8.03% |
04-30 | Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
04-30 | Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
The company’s management will webcast a corresponding conference call beginning at
About
With its corporate headquarters in
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-8.03% | 343M | |
+22.92% | 44.96B | |
+0.99% | 42.65B | |
+46.06% | 41.85B | |
-4.27% | 29.04B | |
+10.63% | 26.08B | |
-20.74% | 19.03B | |
+5.39% | 12.75B | |
+27.54% | 12.06B | |
-4.20% | 11.75B |